Patents for C07C 271 - Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups (15,621) |
---|
03/30/2004 | US6713580 Quaternary amino acids on solid supports |
03/30/2004 | US6713464 Derivatives of 3,3-diphenylpropylamines |
03/30/2004 | CA2194502C 2-[1',2',4'-triazol-3'-yloxymethylene]anilides, their preparation and their use |
03/30/2004 | CA2130755C Intermediates useful in the preparation of purine nucleoside analogues |
03/25/2004 | WO2004024755A2 Sarcolysyl derivatives and method for the production thereof |
03/25/2004 | WO2004024737A1 Method for the organometallic production of organic intermediate products comprising carbon-heteroatom bonds achieved by the deprotonation of heteroatoms |
03/25/2004 | WO2004024081A2 Acetyl 2-hydroxy-1,3 diaminoalkanes |
03/25/2004 | WO2003104167A3 Cyanohydrin ethers and esters as high-sensitivity enzyme substrates |
03/25/2004 | WO2003069350A3 Small molecule modulators of apoptosis |
03/25/2004 | WO2003066549A3 Synthesis of sulfamidates |
03/25/2004 | WO2002088085A3 Methods and intermediates for preparing 4-aminoquinoline cetp inhibitors |
03/25/2004 | US20040059158 Method of friedel-crafts acylation of anilides |
03/25/2004 | US20040059149 Method for the synthesis of compounds of formula 1 and derivatives thereof |
03/25/2004 | US20040059129 2,5-bisphenyl-delta1-pyrroline derivative are chromatographed on a stationary chiral silica gel phase in presence of an eluent or mixture as liquid phase |
03/25/2004 | US20040058820 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis |
03/25/2004 | CA2498248A1 Acetyl 2-hydroxy-1,3 diaminoalkanes |
03/24/2004 | EP1399431A2 Novel nitriles useful as reversible inhibitors of cysteine proteases |
03/24/2004 | EP1399148A2 Multifunctional carbonates and derivatives |
03/24/2004 | EP1318990B1 Process for preparing optically active epoxides |
03/24/2004 | EP1285018B1 Radically polymerisable compositions containing monofunctional monomers, resins and ophthalmic articles obtained from them, new monofunctional monomers |
03/24/2004 | CN1142922C Intermediate used in preparing oxidiazine and its manufacturing method |
03/24/2004 | CN1142904C One-step process synthetizing 2-oxazolidone derivative interediate and preparation process thereof |
03/23/2004 | US6710203 Reacting aqueous ammonium hydroxide and a cyclic carbonate to obtain hydroxyalkylcarbamate |
03/23/2004 | US6710200 Using reporter molecule derivative having aldehyde or ketone group detectable by fluorescence emission, ultraviolet radiation, absorptivity or colorimetric analysis; rearrangements |
03/23/2004 | US6710157 Adding the polycarbamates to regulate the viscosity of the coatings automotives finishes |
03/23/2004 | US6710089 Substituted N-fused-phenyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
03/18/2004 | WO2004022523A2 1, 3-diamino-2-hydroxypropane prodrug derivatives |
03/18/2004 | WO2004001055A3 Pna prodrugs |
03/18/2004 | WO2003099192A3 Bis-aromatic alkanols |
03/18/2004 | WO2003018535A3 Novel aminobenzoephenones |
03/18/2004 | US20040054216 Method for producing lysine derivative |
03/18/2004 | DE10239832A1 New sarcolysine derivatives, e.g. amide or peptide compounds, useful as anticancer agents with reduced toxicity to healthy cells |
03/18/2004 | CA2497979A1 1, 3-diamino-2-hydroxypropane prodrug derivatives |
03/17/2004 | EP1398310A1 Process for the production of optically active amino alcohols |
03/17/2004 | EP1397382A2 Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions |
03/17/2004 | EP1397362A2 Triazolopyrimidines having a fungicidal effect |
03/17/2004 | EP1397340A2 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors |
03/17/2004 | EP0998488B1 Polyol-amino acid compounds having anti-helicobacter pylori activity |
03/17/2004 | CN1483017A Process for the production of 1, 5-naphthalenediamine |
03/16/2004 | US6706924 Process for the production of 1,5-naphthalenediamine |
03/16/2004 | US6706881 Methods for preparing CETP inhibitors |
03/16/2004 | US6706796 For latex; stable suspension |
03/16/2004 | CA2139348C Improved chemiluminescent 1,2-dioxetanes |
03/11/2004 | WO2004020385A1 Process for preparing nitrooxyalkyl substituted esters of carboxylic acids, intermediates useful in said process and preparation thereof |
03/11/2004 | WO2004020384A1 Process for preparing nitrooxyderivatives of naproxen |
03/11/2004 | WO2003097587A3 Gelling agents |
03/11/2004 | US20040049037 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
03/11/2004 | US20040048894 Compounds which mimic the chemical and biological properties of discodermolide |
03/11/2004 | US20040048857 Treatment and/or prevention of diseases or disorders mediated by lymphocyte interactions. |
03/11/2004 | US20040048834 Antitumoral compounds |
03/11/2004 | US20040048797 Regulation of TNF-alpha |
03/11/2004 | US20040047709 Locking nut, bolt and clip systems and assemblies |
03/11/2004 | DE10240260A1 Formation of heteroatom-carbon bonds, giving products of interest for the pharmaceutical and agrochemical industries, comprises using an organolithium compound prepared by reacting an aliphatic or aromatic halide with lithium |
03/10/2004 | EP1395551A2 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases |
03/10/2004 | EP1085010B1 Phenylacetylene derivatives and agricultural/horticultural bactericides |
03/10/2004 | EP1084101B1 New 3-aryl-2-hydroxypropionic acid derivative iii |
03/10/2004 | CN1481369A Substituted phenyluracils compound |
03/10/2004 | CN1481358A Carboxylic acid amide derivatives and their use in treatment of thromboembolic diseases and tumours |
03/09/2004 | US6703522 Alkyl amino acid derivatives useful as pharmaceutical agents |
03/09/2004 | US6703467 Adhesives and sealants |
03/09/2004 | US6702705 Prodrugs activated by targeted catalytic proteins |
03/04/2004 | WO2003088917A3 Regulation of tnf-alpha |
03/04/2004 | WO2002038540A9 Activity-dependent cysteine protease profiling reagent |
03/04/2004 | US20040044242 Using a trifluorosulfonate salt of bismuth, rare earth eleements |
03/04/2004 | US20040044233 Nucleophilic kinetic resolution of cyclic substrates using silyl azides |
03/04/2004 | US20040044201 Bone disorders; osteoporosis; oral diseases; antiarthritic agents |
03/04/2004 | US20040044072 Substituted hydroxyethylamines |
03/03/2004 | EP1394147A1 Carboxylic acid derivative and medicine comprising salt or ester of the same |
03/03/2004 | EP1392695A2 Triazolopyrimidines |
03/03/2004 | EP1392693A1 Triazolopyrimidines |
03/03/2004 | EP1392655A2 Potassium channel openers |
03/03/2004 | EP1392279A1 Trimethyl lock based tetrapartate prodrugs |
03/03/2004 | EP1392204A2 Bifunctional energy-reversible acyl-compositions |
03/03/2004 | EP0929217B1 Sordarin derivatives |
03/03/2004 | CN1479718A Aryl and heteroarylcyclopropyl oximie ethers and their use as fungicides |
03/03/2004 | CN1479715A Amide for inhibition of IL-8-induced chemiotaxis of neutrophil leucocytes |
03/03/2004 | CN1479714A Optically active amine derivative and method of synthesis |
03/03/2004 | CN1140505C Improved method for synthesizing amino formic acid ester compound |
03/02/2004 | US6699994 Biaryl compounds as serine protease inhibitors |
03/02/2004 | US6699904 PPAR agonists |
03/02/2004 | US6699898 Method of treating coronary artery disease or other cetp-mediated disorders in a subject by administering a therapeutically effective amount of a compound of one of claims |
03/02/2004 | US6699893 Glucocorticoid receptor modulators |
03/02/2004 | US6699467 As carriers for delivering active agents such as peptides, drugs by administration, such as oral, subcutaneous, sublingual, and intranasal administration |
02/26/2004 | WO2004016580A2 Derivatives of glycinergic r(+)-2-amino-3-hydroxypropanoic acid |
02/26/2004 | WO2003059898A3 Eponemycin and epoxomicin analogs and uses thereof |
02/26/2004 | US20040039224 T-butoxycarbonylaminoethylamine for the synthesis of pna monomer units, amino acid derivatives, intermediates thereof, and processes for productions of them |
02/26/2004 | US20040039038 Biaromatic compound activators of PPARy-type receptors |
02/26/2004 | US20040039034 Hydroxypropyl amides for the treatment of Alzheimer's disease |
02/26/2004 | US20040038858 Carboxamide derivatives and their use in the treatment of thromboembolic diseases and tumours |
02/26/2004 | US20040037802 Activated polymeric bicine derivatives such as polypeptides modified with these polymers exhibit reduced immunogenicity/antigenicity and circulate in the blood |
02/26/2004 | CA2497347A1 R(+)-2-amino-3-hydroxypropanoic acid derivatives with glycinergic action |
02/25/2004 | EP1390342A2 Substituted aromatic amide derivative, intermediate thereof, agrohorticultural insecticide containing thereof and method for the use thereof |
02/25/2004 | EP1390340A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
02/25/2004 | EP1005446B1 N-aroylphenylalanine derivatives |
02/25/2004 | EP0873301B1 Indane compounds with smooth muscle relaxing and/or mast cell stabilising and/or anti-inflammatory activity |
02/24/2004 | US6696571 Process for producing α-aminoketones |
02/24/2004 | US6696494 α-hydroxyarylbutanamine inhibitors of aspartyl protease |
02/24/2004 | US6696487 Fungicidal phenyl(thio)urea and phenyl(thio)carbamate derivatives |
02/24/2004 | US6696475 Substituted phenyl derivatives, their preparation and use |
02/24/2004 | US6696472 Substituted N-phenoxy-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |